Results 11 to 20 of about 43,370 (253)

Endocrine Therapy Resistance-Associated ERα-Y537S Mutation Alters ERα/PR Crosstalk in Breast Cancer [PDF]

open access: yes, 2023
Background: Half of estrogen receptor (ERα)-positive breast cancer patients treated with endocrine therapies manifest intrinsic or acquired therapy resistance.
Huggins, Rosemary Joan
core   +1 more source

MOF negatively regulates estrogen receptor α signaling via CUL4B-mediated protein degradation in breast cancer

open access: yesFrontiers in Oncology, 2022
Estrogen receptor α (ERα) is the dominant tumorigenesis driver in breast cancer (BC), and ERα-positive BC (ERα+ BC) accounts for more than two-thirds of BC cases.
Xu Zhang   +9 more
doaj   +1 more source

Estrogen receptor α phosphorylated at Ser216 confers inflammatory function to mouse microglia

open access: yesCell Communication and Signaling, 2020
Background Estrogen receptor α (ERα) has been suggested to regulate anti-inflammatory signaling in brain microglia, the only resident immune cells in the brain. ERα conserves the phosphorylation motif at Ser216 within the DNA binding domain.
Sawako Shindo   +10 more
doaj   +1 more source

Small leucine zipper protein functions as a negative regulator of estrogen receptor α in breast cancer. [PDF]

open access: yesPLoS ONE, 2017
The nuclear transcription factor estrogen receptor α (ERα) plays a critical role in breast cancer progression. ERα acts as an important growth stimulatory protein in breast cancer and the expression level of ERα is tightly related to the prognosis and ...
Juyeon Jeong   +4 more
doaj   +1 more source

Gene expression of estrogen receptor during different stages of pregnancy in rats model [PDF]

open access: yesIraqi Journal of Veterinary Sciences
One essential organ that steroid hormones target is the uterus and ovaries. Many receptors mediate the effects of these hormones such as estrogen receptors ER.
Enas O. Al-Babily, Barra D. Al-Watar
doaj   +1 more source

MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α

open access: yesCell Death and Disease, 2021
Breast cancer is the most commonly diagnosed malignant tumor among females. Estrogen receptor α (ERα) is initially expressed in 70% of breast cancers and is a well-known target of endocrine therapy for ERα-positive breast cancer. In the present study, we
Jianing Tang   +3 more
doaj   +1 more source

Both Nuclear and Membrane Estrogen Receptor Alpha Impact the Expression of Estrogen Receptors and Plasticity Markers in the Mouse Hypothalamus and Hippocampus

open access: yesBiology, 2023
Estrogens via estrogen receptor alpha (ERα) genomic and nongenomic signaling can influence plasticity processes in numerous brain regions. Using mice that express nuclear only ERα (NOER) or membrane only ERα (MOER), this study examined the effect of ...
Sanoara Mazid   +7 more
doaj   +1 more source

Investigating the Erα and Cyclin D1 Gene Expression Levels, Changes in SOD, NO, and MDA Levels, and Histopathology of Mice Testicular Tissue Treated with AFG1

open access: yesJournal of Mazandaran University of Medical Sciences, 2021
Background and purpose: Previous studies have shown the adverse effects of aflatoxin G1 on testicular tissue and the process of spermatogenesis. The aim of this study was to investigate changes in the expression of Cyclin D1, the estrogen receptor ERα ...
Toraj Zamir-nasta   +3 more
doaj  

Screening 2‒mercaptoimidazole derivatives for breast cancer treatment

open access: yesTạp chí Khoa học và Công nghệ, 2023
2‒Mecaptoimidazole (2MC), its tautomer (2MI), and derivatives were evaluated in silico for their antioxidant activity and potential for breast cancer drug development.
Tran Viet Anh   +4 more
doaj  

TRIM16 transcription factor in prostate cancer

open access: yesБюллетень сибирской медицины, 2018
The aim of this investigation was to reveal the expression TRIM16, ERα, ERβ and AR in prostate cancer tissues compared to benign hyperplasia and clinical and morphological parameters.Materials and methods.
L. V. Spirina   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy